Does your child have moderate to severe eczema?

We are currently enrolling children aged 2-11 for an eczema study

Compensation up to $100

Interested in learning more about this study?

Please enter your information below, and one of our study coordinators will contact you regarding the study.

About the Study

We are currently recruiting children with moderate to severe eczema for a study that investigates the safety and tolerability of 1.5% ruxolitinib cream (FDA approved Opzelura). The study drug consists of a topical application of the drug that will be applied for 8 weeks in the morning and in the evening. This treatment is FDA approved and all study participants will receive the study medication.

Compensation is up to $100

How to Participate

Blood samplings will be collected at screening, Day 1, weeks 4 and 8. Additional plasma and saliva samplings will be collected at Day 1, weeks 2, 4 and 8. Photographs of the lesions will be taken at Day 1, weeks 2, 4 and 8. During the study visits, a physical evaluation of your child’s eczema and overall health will be done with the study team.

At the end of the 8 weeks, participants may be eligible to participate in the long-term safety period for another 44 weeks when they will continue receiving the study treatment. More information will be made available to the participants should they be interested.)

This study will last (including the long-term safety) a period of up to year 16 visits and 2 phone calls; Visits take approximately 1 to 3 hours each.

Taking part in this study is voluntary and there is no penalty or change to your child’s regular medical care if they decide not to participate. We encourage you and your child to have conversations with family, caregivers, doctors and the study team about taking part in this study and whether it is right for them.

Is Your Child Eligible?

Your child may be eligible to participate in this clinical study if they:

  • Your child is aged ≥2 years to < 12 years

  • Your child has been suffering from atopic dermatitis for at least 3 months

Note: These are not the only eligibility criteria for this clinical research study, and other criteria may exclude your child. A clinical research team member will help determine if your child meets all necessary criteria to participate.